Hepatitis NSW, May 2020 Since the COVID-19 virus is so new and can be life threatening, there are many unknown factors at play. This is even more so for people with pre-existing health conditions to consider. To help address those concerns and to answer the frequently asked questions, Hepatitis NSW has now compiled a number of online resources. All pages are based on the most up to date...
SHINE SA, May 5, 2020 SHINE SA will now temporarily provide a full 28-day supply of Post-exposure Prophylaxis (PEP) medication in place of the usual five-day starter pack. This measure has been put in place with the assistance of SA Health to help limit movement during the COVID-19 pandemic. Prior to the pandemic, clients received a five-day HIV PEP starter pack and then the remaining medication...
Thorne Harbour Health – media release, 26 March 2020 For the first time in its four-decade history, Thorne Harbour Health is calling on communities to stop having casual sex in the face of 2019 novel coronavirus (COVID-19). Thorne Harbour Health, formerly the Victorian AIDS Council, is calling on LGBTI communities and people living with HIV to limit their risk of COVID-19 transmission...
CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...
High-risk behaviors and their association with awareness of HIV status among participants of a large-scale prevention intervention in Athens, Greece. Pavlopoulou, I.D., Dikalioti, S.K., Gountas, I. et al. BMC Public Health 20, 105 (2020). Abstract Background Aristotle was a seek-test-treat intervention during an outbreak of human immunodeficiency virus (HIV) infection among people who inject...
International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019) Nearly 200 pages of open access articles from projects and research around the world. While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where...